NCT05660629 is a NA clinical trial of Mulligan Mobilization in Rheumatoid Arthritis, sponsored by Kirsehir Ahi Evran Universitesi.

Who is sponsoring NCT05660629?

NCT05660629 is sponsored by Kirsehir Ahi Evran Universitesi.

What drugs are being tested in NCT05660629?

Interventions in NCT05660629: Mulligan Mobilization.

What condition does NCT05660629 study?

NCT05660629 studies Rheumatoid Arthritis.

Is NCT05660629 still recruiting?

NCT05660629 is currently completed. Last updated 17 December 2024.

Last reviewed 2024-12-17 · How we verify

NCT05660629

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Mulligan Mobilization in Rheumatoid Hand

Completed NA Last updated 17 December 2024

What this trial tests

NA trial testing Mulligan Mobilization in Rheumatoid Arthritis in 21 participants. Completed in 12 December 2024.

Timeline

30 October 2023

Primary endpoint
11 December 2024

12 December 2024

Quick facts

Lead sponsor	Kirsehir Ahi Evran Universitesi
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	21
Start date	30 October 2023
Primary completion	11 December 2024
Estimated completion	12 December 2024
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

Mulligan Mobilization

Conditions studied

Rheumatoid Arthritis — all drugs for Rheumatoid Arthritis →

Sponsor

Kirsehir Ahi Evran Universitesi — full company profile →

Who can join

Adults 30 to 65, any sex, with Rheumatoid Arthritis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this randomized-controlled study is to learn about the effectiveness of the Mulligan mobilization in rheumatoid hands. The main question it aims to answer are: -Does mulligan mobilization reduce effusion in wrist joints with rheumatoid arthritis? Participants will take Mulligan mobilization application and active ROM exercises for their hands. Researcher will compare treatments group ith sham mobilization.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

The effect of mobilization with movement on pain, joint distance, effusion area, and inflammation in rheumatoid arthritis: a double-blind randomized controlled clinical trial.
Özçelep ÖF, Tunali N, Turhan A, Polat E, et al · · 2025 · cited 1× · PMID 41152887 · DOI 10.1186/s13018-025-06121-3

Verify or expand the search:

Other trials of Mulligan Mobilization

Trials testing the same drug.

NCT07294729 — Mulligan and Proprioceptive Neuromuscular Facilitation Techniques in Individuals With Rotator Cuff Lesions · NA · active not recruiting
NCT07328269 — Effects of Mulligan Mobilization in Comparison With Maitland Mobilization in Temporomandibular Joint Dysfunction. · NA · recruiting
NCT06927115 — Comparative Analysis of Mulligan and Maitland Mobilizations Techniques in Adhesive Capsulitis · NA · completed
NCT06954363 — Effectiveness of Muscle Energy Techniques and Mulligan Mobilization Along With Conventional Physical Therapy in Knee Joi · NA · completed
NCT06474897 — Comparison of Mobilization and Ozone Therapy in Impingement Syndrome · NA · recruiting

Other recruiting trials for Rheumatoid Arthritis

Currently open trials in the same condition.

NCT07433335 — A Study to Assess the Safety and Tolerability of SR-878 in Patients With Rheumatoid Arthritis · Phase 1 · recruiting
NCT07491016 — Efficacy and Safety of Telitacicept Combined With Baricitinib for Refractory Rheumatoid Arthritis · recruiting
NCT07171983 — A Study to Evaluate the Safety, Tolerability, and Drug Levels of BMS-986454 in Participants With Rheumatoid Arthritis · Phase 1 · recruiting
NCT07246096 — Exploratory Clinical Study on the Safety and Efficacy of Anti- CD19/BCMA U CAR-T Cell Injection for the Treatment of Rel · EARLY_PHASE1 · recruiting
NCT07363590 — A Clinical Study of MK-1045 in People With Lupus or Rheumatoid Arthritis (MK-1045-004) · Phase 1 · recruiting

Other Kirsehir Ahi Evran Universitesi trials

Trials by the same sponsor.

NCT07506915 — The Effect of Cognitive Behavioral Therapy · NA · enrolling by invitation
NCT07502248 — PENG Block With or Without PPD Block for Postoperative Analgesia After Total Hip Arthroplasty · NA · not yet recruiting
NCT07438392 — Tecar Therapy in Chronic Knee Osteoarthritis · NA · not yet recruiting
NCT07450742 — Digital Storytelling and Mother's Knowledge and Attitudes Towards Newborn Screning · NA · not yet recruiting
NCT07414017 — Comparison of Focus of Attention in Virtual Reality-Based Exercise Training in Older Adults With Low Back Pain · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05660629 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Kirsehir Ahi Evran Universitesi
Last refreshed: 17 December 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05660629.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing